Scholarlink

<p>This study aimed to evaluate the therapeutic action of tannic acid (TA) in male Swiss mice by investigating: i) the involvement of the serotonergic system in the acute TA antidepressant-like action per se using pharmacological tools, and ii) the neuroprotective activity of TA in a lipopolysaccharide (LPS)-induced depressive-like behavior. For mechanistic investigation of the acute TA antidepressant-like action, mice received i.p. the serotoninergic receptor antagonists: WAY-100135 (5-HT<sub>1 A</sub> antagonist), ketanserin (5-HT<sub>2 A/2 C</sub> antagonist), or ondansetron (5-HT<sub>3</sub> antagonist); 15&#xa0;min later, TA or water was given by gavage. After 1&#xa0;h, mice were subjected to a tail suspension test (TST). TA in different doses was tested in acute open field test (OFT), TST, and forced swimming test (FST). In the LPS protocol, animals were pretreated once daily with TA (60 or 120&#xa0;mg/kg), fluoxetine (20&#xa0;mg/kg) or vehicle for 7&#xa0;days. On the 7th day, mice received a single injection of LPS (830&#xa0;μg/kg, i.p.). After 24&#xa0;h, OFT and TST were assessed. Behavioral data concerning the acute antidepressant-like effects of TA demonstrated that this tannin acts via 5-HT<sub>1 A</sub> and 5-HT<sub>2 A/2 C</sub> receptors. Besides, monoamine oxidase A (MAO-A) in vitro activity was determined in total brain; the polyphenol action was able to decrease enzyme activity. In the LPS-induced depression model, TA prevented the increase in LPS-induced immobility time in the TST, downregulated the expression of NF-κB and IL-1β, and modulated MAO-A activity in the cerebral cortex. In conclusion, TA exhibited neuroprotective and antidepressant-like activities in mice, positioning it as a promising candidate for depression therapeutics.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Elucidating the Antidepressant-Like Effect of Tannic Acid in Mice: Modulation of Serotonergic System and Pro-Inflammatory Mediators

  • 期刊论文

  • 发表日期：

    2025年5月27日

查看全文
  • Karina Pereira Luduvico,
  • Julia Eisenhardt de Mello,
  • Solange Vega Custódio,
  • Evelyn Mianes Besckow,
  • César Augusto Brüning,
  • Cristiani Folharini Bortolatto,
  • Lucas Petitemberte de Souza,
  • William Borges Domingues,
  • Vinicius Farias Campos,
  • Roselia Maria Spanevello,
  • Francieli Moro Stefanello

摘要

This study aimed to evaluate the therapeutic action of tannic acid (TA) in male Swiss mice by investigating: i) the involvement of the serotonergic system in the acute TA antidepressant-like action per se using pharmacological tools, and ii) the neuroprotective activity of TA in a lipopolysaccharide (LPS)-induced depressive-like behavior. For mechanistic investigation of the acute TA antidepressant-like action, mice received i.p. the serotoninergic receptor antagonists: WAY-100135 (5-HT1 A antagonist), ketanserin (5-HT2 A/2 C antagonist), or ondansetron (5-HT3 antagonist); 15 min later, TA or water was given by gavage. After 1 h, mice were subjected to a tail suspension test (TST). TA in different doses was tested in acute open field test (OFT), TST, and forced swimming test (FST). In the LPS protocol, animals were pretreated once daily with TA (60 or 120 mg/kg), fluoxetine (20 mg/kg) or vehicle for 7 days. On the 7th day, mice received a single injection of LPS (830 μg/kg, i.p.). After 24 h, OFT and TST were assessed. Behavioral data concerning the acute antidepressant-like effects of TA demonstrated that this tannin acts via 5-HT1 A and 5-HT2 A/2 C receptors. Besides, monoamine oxidase A (MAO-A) in vitro activity was determined in total brain; the polyphenol action was able to decrease enzyme activity. In the LPS-induced depression model, TA prevented the increase in LPS-induced immobility time in the TST, downregulated the expression of NF-κB and IL-1β, and modulated MAO-A activity in the cerebral cortex. In conclusion, TA exhibited neuroprotective and antidepressant-like activities in mice, positioning it as a promising candidate for depression therapeutics.